NCT00524121View on ClinicalTrials.gov

Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

October 31, 2011

Conditions
Esophageal Cancer
Interventions
DRUG

erlotinib hydrochloride

Oral

OTHER

immunohistochemistry staining method

Correlative Study

RADIATION

radiation therapy

Radiation Treatment

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00524121 - Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer | Biotech Hunter | Biotech Hunter